Great Point Partners LLC Aclaris Therapeutics, Inc. Transaction History

Great Point Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $1.64 Million - $2.74 Million	-249,813 Reduced 12.87%	1,691,768 $11.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $5.92 Million - $7.98 Million	750,000 Added 62.94%	1,941,581 $20.1 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $1.22 Million - $3.09 Million	172,299 Added 16.9%	1,191,581 $9.64 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $832,794 - $1.16 Million	-63,718 Reduced 5.88%	1,019,282 $16 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $1.43 Million - $2.4 Million	140,555 Added 14.91%	1,083,000 $15.1 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $1.39 Million - $2.55 Million	142,445 Added 17.81%	942,445 $16.2 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $3.68 Million - $5.55 Million	300,000 Added 60.0%	800,000 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $6.69 Million - $9.4 Million	500,000 New	500,000 $9 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.